ESTRAMON estradiol 25 microgram/24 hours transdermal patch (Hexal, Germany)
Section 19A approved medicine
ESTRAMON estradiol 25 microgram/24 hours transdermal patch (Hexal, Germany)
Section 19A approval holder
Sandoz Pty Ltd ABN 60 754 449 553
Phone
1800 726 369
Approved until
Status
Current
Medicines in short supply/unavailable
ESTRADOT 25 estradiol 25 microgram transdermal drug delivery system sachet - ARTG 338056
Indication(s)
Short term treatment of symptoms of estrogen deficiency due to the menopause, whether natural or surgically induced.
In women with an intact uterus, estrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals.
Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.
Additional information
Please note: CONTAINS SOYBEAN OIL. The section 19A approved medicine is contraindicated in patients with known hypersensitivity to the active ingredient, soy, peanut or any of the other ingredients listed. Prior to dispensing and administering, healthcare professionals should determine if this product is suitable for the patient.
Images
